000766 通化金马
已收盘 12-19 15:00:00
资讯
新帖
简况
12月16日通化金马现1笔大宗交易 机构净买入201.88万元
证券之星 · 12-16
12月16日通化金马现1笔大宗交易 机构净买入201.88万元
通化金马:12月12日接受机构调研,广发证券、申万宏源证券参与
证券之星 · 12-13
通化金马:12月12日接受机构调研,广发证券、申万宏源证券参与
12月6日通化金马涨10.03%,易方达中证1000ETF联接A基金重仓该股
证券之星 · 12-06
12月6日通化金马涨10.03%,易方达中证1000ETF联接A基金重仓该股
异动快报:通化金马(000766)12月6日10点11分触及涨停板
证券之星 · 12-06
异动快报:通化金马(000766)12月6日10点11分触及涨停板
通化金马最新公告:子公司预计投资不超过1亿元建设人工繁育麝香基地
证券之星 · 11-27
通化金马最新公告:子公司预计投资不超过1亿元建设人工繁育麝香基地
通化金马:子公司预计投资不超过1亿元建设人工繁育麝香基地
美港电讯 · 11-27
通化金马:子公司预计投资不超过1亿元建设人工繁育麝香基地
11月20日通化金马现1笔大宗交易 机构净买入202.16万元
证券之星 · 11-20
11月20日通化金马现1笔大宗交易 机构净买入202.16万元
通化金马:董秘回答关于具有融资融券业务的证券公司
问董秘 · 11-12
通化金马:董秘回答关于具有融资融券业务的证券公司
通化金马(000766)2024年三季报简析:净利润增53.84%
证券之星 · 10-22
通化金马(000766)2024年三季报简析:净利润增53.84%
通化金马(000766.SZ)发布前三季度业绩,净利润2392.37万元,增长53.84%
智通财经 · 10-20
通化金马(000766.SZ)发布前三季度业绩,净利润2392.37万元,增长53.84%
通化金马(000766)9月30日股东户数4.92万户,较上期增加2.93%
证券之星 · 10-20
通化金马(000766)9月30日股东户数4.92万户,较上期增加2.93%
图解通化金马三季报:第三季度单季净利润同比增139.97%
证券之星 · 10-20
图解通化金马三季报:第三季度单季净利润同比增139.97%
通化金马最新公告:前三季度净利润2392.37万元 同比增长53.84%
证券之星 · 10-20
通化金马最新公告:前三季度净利润2392.37万元 同比增长53.84%
通化金马最新公告:琥珀八氢氨吖啶片获15国PCT专利保护
证券之星 · 10-15
通化金马最新公告:琥珀八氢氨吖啶片获15国PCT专利保护
通化金马(000766.SZ):琥珀八氢氨吖啶片的原料药和制剂已获国家药监局上市申请受理
智通财经 · 10-15
通化金马(000766.SZ):琥珀八氢氨吖啶片的原料药和制剂已获国家药监局上市申请受理
10月14日通化金马涨7.45%,南方中证1000ETF基金重仓该股
证券之星 · 10-14
10月14日通化金马涨7.45%,南方中证1000ETF基金重仓该股
10月9日通化金马跌9.90%,南方中证1000ETF基金重仓该股
证券之星 · 10-09
10月9日通化金马跌9.90%,南方中证1000ETF基金重仓该股
通化金马(000766)10月8日主力资金净卖出2.19亿元
证券之星 · 10-09
通化金马(000766)10月8日主力资金净卖出2.19亿元
通化金马(000766)9月30日主力资金净卖出1.07亿元
证券之星 · 10-08
通化金马(000766)9月30日主力资金净卖出1.07亿元
9月30日通化金马涨6.71%,南方中证1000ETF基金重仓该股
证券之星 · 09-30
9月30日通化金马涨6.71%,南方中证1000ETF基金重仓该股
加载更多
公司概况
公司名称:
通化金马药业集团股份有限公司
所属行业:
医药制造业
上市日期:
1997-04-30
主营业务:
通化金马药业集团股份有限公司主要从事医药产品的研发、生产与销售。主要产品有复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾口服液、芩石利咽口服液。公司经历多年发展,获得行业认可,荣获“中华民族医药百强品牌企业”,2023年获得“2022-2023年度中国医药制造业百强”等称号。子公司圣泰生物先后被评为哈尔滨市“小巨人”企业、黑龙江省民营科技“巨星”企业、黑龙江省专精特新小巨人企业、国家高新技术企业、国家火炬计划重点高新技术企业等多项荣誉。
发行价格:
7.23
{"stockData":{"symbol":"000766","market":"SZ","secType":"STK","nameCN":"通化金马","latestPrice":15.36,"timestamp":1734591813000,"preClose":15.34,"halted":0,"volume":11662342,"delay":0,"floatShares":966000000,"shares":966000000,"eps":0.0542,"marketStatus":"已收盘","marketStatusCode":5,"change":0.02,"latestTime":"12-19 15:00:00","open":15.24,"high":15.53,"low":15.1,"amount":179000000,"amplitude":0.028,"askPrice":15.37,"askSize":243,"bidPrice":15.36,"bidSize":182,"shortable":0,"etf":0,"ttmEps":0.0542,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":15.34,"symbolType":"stock","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":16.87,"lowLimit":13.81,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":966494707,"pbRate":6.33,"roa":"--","roe":"1.03%","epsLYR":0.05,"committee":-0.071529,"marketValue":14845000000,"floatMarketCap":14838000000,"peRate":283.394828,"changeRate":0.0013,"turnoverRate":0.0121,"status":0},"requestUrl":"/m/hq/s/000766","defaultTab":"news","newsList":[{"id":"2491654599","title":"12月16日通化金马现1笔大宗交易 机构净买入201.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491654599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491654599?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:47","pubTimestamp":1734338874,"startTime":"0","endTime":"0","summary":"证券之星消息,12月16日通化金马发生大宗交易,交易数据如下:大宗交易成交价格16.15元,成交12.5万股,成交金额201.88万元,买方营业部为机构专用,卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生2笔大宗交易,合计成交2650.0手。该股近期无解禁股上市。截至2024年12月16日收盘,通化金马(000766)报收于16.15元,上涨0.69%,换手率2.16%,成交量20.91万手,成交额3.39亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600021273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0060","BK0239","BK0077"],"gpt_icon":0},{"id":"2491269583","title":"通化金马:12月12日接受机构调研,广发证券、申万宏源证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2491269583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491269583?lang=zh_cn&edition=full","pubTime":"2024-12-13 19:32","pubTimestamp":1734089556,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年12月13日通化金马发布公告称公司于2024年12月12日接受机构调研,广发证券李安飞、申万宏源证券仰佳佳参与。新药获批后,将为广大阿尔茨海默病患者带来更好的治疗选择。通化金马主营业务:医药产品的研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300039546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","161027","BK0028","BK1564","BK0077","01776","BK0060","000766","000776","BK0188","BK0239","BK0012","06806","000166","BK0276","SG9999001093.SGD","BK1147"],"gpt_icon":0},{"id":"2489408134","title":"12月6日通化金马涨10.03%,易方达中证1000ETF联接A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489408134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489408134?lang=zh_cn&edition=full","pubTime":"2024-12-06 16:08","pubTimestamp":1733472511,"startTime":"0","endTime":"0","summary":"证券之星消息,12月6日通化金马涨10.03%,收盘报15.79元,换手率6.74%,成交量65.08万手,成交额10.11亿元。重仓通化金马的公募基金请见下表:根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为易方达中证1000ETF联接A。易方达中证1000ETF联接A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600025993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0060","000766","512100"],"gpt_icon":0},{"id":"2489423626","title":"异动快报:通化金马(000766)12月6日10点11分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2489423626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489423626?lang=zh_cn&edition=full","pubTime":"2024-12-06 10:15","pubTimestamp":1733451319,"startTime":"0","endTime":"0","summary":"证券之星12月6日盘中消息,10点11分通化金马(000766)触及涨停板。目前价格15.79,上涨10.03%。其所属行业化学制药目前下跌。领涨股为通化金马。该股为林业,阿尔茨海默病,医药概念热股,当日林业概念上涨1.21%,阿尔茨海默病概念上涨0.03%。12月5日的资金流向数据方面,主力资金净流出328.04万元,占总成交额2.07%,游资资金净流入638.54万元,占总成交额4.03%,散户资金净流出310.5万元,占总成交额1.96%。近5日资金流向一览见下表:通化金马主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600012061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0077","BK0239","000766"],"gpt_icon":0},{"id":"2486845505","title":"通化金马最新公告:子公司预计投资不超过1亿元建设人工繁育麝香基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2486845505","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486845505?lang=zh_cn&edition=full","pubTime":"2024-11-27 17:41","pubTimestamp":1732700480,"startTime":"0","endTime":"0","summary":"通化金马公告,基于未来发展战略及业务发展需要,为进一步提升永康制药的综合竞争力,建立以麝香为核心支点的全产业链发展优势,同意永康制药实施建设人工繁育麝香基地,本项目预计投资金额不超过10,000万元。项目计划2025年6月底前完成圈舍及配套设施建设、设备购置、种源引进等工作。通过此次基地建设项目,扩大林麝养殖规模,延展麝香产业链,实现“林麝养殖、原料提取、制剂生产、创新研发”的麝香全产业链布局。本次投资建设资金来源为自有资金或自筹资金,预计对公司当期财务状况和经营成果不构成重大影响,对未来年度财务状况和经营成果有积极影响。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700030854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0077","000766"],"gpt_icon":0},{"id":"2486555843","title":"通化金马:子公司预计投资不超过1亿元建设人工繁育麝香基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2486555843","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486555843?lang=zh_cn&edition=full","pubTime":"2024-11-27 17:28","pubTimestamp":1732699708,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","BK0077","BK0239","01477","BK0060","000766","BK1191"],"gpt_icon":0},{"id":"2484169659","title":"11月20日通化金马现1笔大宗交易 机构净买入202.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484169659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484169659?lang=zh_cn&edition=full","pubTime":"2024-11-20 16:46","pubTimestamp":1732092418,"startTime":"0","endTime":"0","summary":"证券之星消息,11月20日通化金马发生大宗交易,交易数据如下:大宗交易成交价格14.44元,成交14万股,成交金额202.16万元,买方营业部为机构专用,卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生3笔大宗交易,合计成交6000.0手。该股近期无解禁股上市。截至2024年11月20日收盘,通化金马(000766)报收于14.44元,上涨0.14%,换手率1.32%,成交量12.74万手,成交额1.84亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000028117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","000766","BK0060"],"gpt_icon":0},{"id":"2482934721","title":"通化金马:董秘回答关于具有融资融券业务的证券公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2482934721","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482934721?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:57","pubTimestamp":1731398220,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 投资者提问:哪家证券可以融券贵公司有价证券?董秘回答(通化金马SZ000766):您好,请咨询具有融资融券业务的证券公司。查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-11-12/doc-incvuxsf9519286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399975","BK0239","159848","000766","BK0060","BK0077"],"gpt_icon":0},{"id":"2477481006","title":"通化金马(000766)2024年三季报简析:净利润增53.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477481006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477481006?lang=zh_cn&edition=full","pubTime":"2024-10-22 06:02","pubTimestamp":1729548175,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期通化金马发布2024年三季报。根据财报显示,通化金马净利润增53.84%。截至本报告期末,公司营业总收入9.69亿元,同比下降7.24%,归母净利润2392.37万元,同比上升53.84%。按单季度数据看,第三季度营业总收入3.19亿元,同比上升1.16%,第三季度归母净利润1145.54万元,同比上升139.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200003826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2476084593","title":"通化金马(000766.SZ)发布前三季度业绩,净利润2392.37万元,增长53.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476084593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476084593?lang=zh_cn&edition=full","pubTime":"2024-10-20 17:17","pubTimestamp":1729415872,"startTime":"0","endTime":"0","summary":"智通财经APP讯,通化金马(000766.SZ)发布2024年三季度报告,该公司前三季度营业收入为9.69亿元,同比减少7.24%。归属于上市公司股东的净利润为2392.37万元,同比增长53.84%。归属于上市公司股东的扣除非经常性损益的净利润为1638.78万元,同比增长51.15%。基本每股收益为0.0248元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000766"],"gpt_icon":0},{"id":"2476081611","title":"通化金马(000766)9月30日股东户数4.92万户,较上期增加2.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476081611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476081611?lang=zh_cn&edition=full","pubTime":"2024-10-20 17:00","pubTimestamp":1729414844,"startTime":"0","endTime":"0","summary":"证券之星消息,近日通化金马披露,截至2024年9月30日公司股东户数为4.92万户,较6月30日增加1402.0户,增幅为2.93%。在化学制药行业个股中,通化金马股东户数高于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.18万户。从股价来看,2024年6月30日至2024年9月30日,通化金马区间涨幅为2.1%,在此期间股东户数增加1402.0户,增幅为2.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102000001250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0239","BK0060","BK0077"],"gpt_icon":0},{"id":"2476086688","title":"图解通化金马三季报:第三季度单季净利润同比增139.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476086688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476086688?lang=zh_cn&edition=full","pubTime":"2024-10-20 16:31","pubTimestamp":1729413101,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马2024年三季报显示,公司主营收入9.69亿元,同比下降7.24%;归母净利润2392.37万元,同比上升53.84%;扣非净利润1638.78万元,同比上升51.15%;其中2024年第三季度,公司单季度主营收入3.19亿元,同比上升1.16%;单季度归母净利润1145.54万元,同比上升139.97%;单季度扣非净利润998.64万元,同比上升218.77%;负债率49.06%,投资收益327.52万元,财务费用5735.92万元,毛利率75.39%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102000001167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2476836620","title":"通化金马最新公告:前三季度净利润2392.37万元 同比增长53.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476836620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476836620?lang=zh_cn&edition=full","pubTime":"2024-10-20 16:00","pubTimestamp":1729411249,"startTime":"0","endTime":"0","summary":"通化金马发布2024年第三季度报告,前三季度实现营业收入9.69亿元,同比下降7.24%;归属于上市公司股东的净利润2392.37万元,同比增长53.84%;基本每股收益0.0248元。其中,第三季度归属于上市公司股东的净利润1145.54万元,同比增长139.97%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102000000997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2475520703","title":"通化金马最新公告:琥珀八氢氨吖啶片获15国PCT专利保护","url":"https://stock-news.laohu8.com/highlight/detail?id=2475520703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475520703?lang=zh_cn&edition=full","pubTime":"2024-10-15 18:21","pubTimestamp":1728987662,"startTime":"0","endTime":"0","summary":"通化金马发布关于国家1类化学药琥珀八氢氨吖啶片相关专利保护情况的自愿性披露公告,琥珀八氢氨吖啶片是一种新型的、强效、作用机制明确的胆碱酯酶抑制剂,是拥有完全自主知识产权、新化学分子结构的化学1类新药,用于轻、中度阿尔茨海默病的治疗。同时,琥珀八氢氨吖啶主要晶型陆续获得国际PCT(专利合作条约)专利保护,其中2022年9月获得日本专利授权。2023年5月获得欧洲授权,具体国家为以下15国:英国、德国、瑞士、瑞典、荷兰、丹麦、芬兰、比利时、法国、奥地利、西班牙、挪威、爱尔兰、希腊、意大利。于2024年9月获得美国专利授权。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101500029704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","000766","BK0060","BK0239"],"gpt_icon":0},{"id":"2475858525","title":"通化金马(000766.SZ):琥珀八氢氨吖啶片的原料药和制剂已获国家药监局上市申请受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2475858525","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475858525?lang=zh_cn&edition=full","pubTime":"2024-10-15 17:10","pubTimestamp":1728983453,"startTime":"0","endTime":"0","summary":"公司研发的琥珀八氢氨吖啶片的原料药和制剂已获得国家药品监督管理局上市申请受理,进入国家药品监督管理局药品审评中心审评审批环节,药品审评审批时间、审批结果及未来产品市场竞争形势均存在诸多不确性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1194159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0239","000766","BK0077"],"gpt_icon":0},{"id":"2475344193","title":"10月14日通化金马涨7.45%,南方中证1000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475344193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475344193?lang=zh_cn&edition=full","pubTime":"2024-10-14 16:16","pubTimestamp":1728893797,"startTime":"0","endTime":"0","summary":"证券之星消息,10月14日通化金马涨7.45%,收盘报15.28元,换手率3.56%,成交量34.41万手,成交额5.06亿元。重仓通化金马的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为南方中证1000ETF。南方中证1000ETF目前规模为241.3亿元,最新净值2.2019,较上一交易日下跌4.22%,近一年下跌9.71%。南方中证1000ETF的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101400019217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","560110","BK0077","BK0060","BK0239"],"gpt_icon":0},{"id":"2474216287","title":"10月9日通化金马跌9.90%,南方中证1000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474216287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474216287?lang=zh_cn&edition=full","pubTime":"2024-10-09 17:14","pubTimestamp":1728465269,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日通化金马跌9.90%,收盘报14.93元,换手率4.89%,成交量47.24万手,成交额7.3亿元。重仓通化金马的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为南方中证1000ETF。南方中证1000ETF的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900030915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["560110","BK0060","BK0077","000766","BK0239"],"gpt_icon":0},{"id":"2474823777","title":"通化金马(000766)10月8日主力资金净卖出2.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474823777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474823777?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:23","pubTimestamp":1728437039,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月8日收盘,通化金马报收于16.57元,上涨0.24%,换手率7.32%,成交量70.73万手,成交额11.93亿元。10月8日的资金流向数据方面,主力资金净流出2.19亿元,占总成交额18.33%,游资资金净流入1.07亿元,占总成交额9.01%,散户资金净流入1.11亿元,占总成交额9.32%。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入1.01亿元,融资偿还1.18亿元,融资净偿还1626.47万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900005766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","000766","BK0060","BK0239"],"gpt_icon":0},{"id":"2473457604","title":"通化金马(000766)9月30日主力资金净卖出1.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473457604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473457604?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:21","pubTimestamp":1728350477,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月30日收盘,通化金马报收于16.53元,上涨6.71%,换手率5.67%,成交量54.78万手,成交额8.9亿元。9月30日的资金流向数据方面,主力资金净流出1.07亿元,占总成交额12.02%,游资资金净流入996.92万元,占总成交额1.12%,散户资金净流入9703.67万元,占总成交额10.9%。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入6168.46万元,融资偿还6428.42万元,融资净偿还259.96万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800001442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","000766","BK0060"],"gpt_icon":0},{"id":"2471874925","title":"9月30日通化金马涨6.71%,南方中证1000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471874925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471874925?lang=zh_cn&edition=full","pubTime":"2024-09-30 17:54","pubTimestamp":1727690081,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日通化金马涨6.71%,收盘报16.53元,换手率5.67%,成交量54.78万手,成交额8.9亿元。重仓通化金马的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为南方中证1000ETF。南方中证1000ETF的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000031546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0060","BK0077","560110","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-04-30","address":"吉林省通化市二道江区金马路999号","stockEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":0.0652},{"period":"3month","weight":0.1082},{"period":"6month","weight":-0.1307},{"period":"1year","weight":-0.2795},{"period":"ytd","weight":-0.2297}],"companyName":"通化金马药业集团股份有限公司","boardCode":"AI0027","perCapita":"19615股","boardName":"医药制造业","registeredCapital":"96649万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 通化金马药业集团股份有限公司主要从事医药产品的研发、生产与销售。主要产品有复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾口服液、芩石利咽口服液。公司经历多年发展,获得行业认可,荣获“中华民族医药百强品牌企业”,2023年获得“2022-2023年度中国医药制造业百强”等称号。子公司圣泰生物先后被评为哈尔滨市“小巨人”企业、黑龙江省民营科技“巨星”企业、黑龙江省专精特新小巨人企业、国家高新技术企业、国家火炬计划重点高新技术企业等多项荣誉。","serverTime":1734627571179,"listedPrice":7.23,"stockholders":"49247人(较上一季度增加2.93%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化金马,000766,通化金马股票,通化金马股票老虎,通化金马股票老虎国际,通化金马行情,通化金马股票行情,通化金马股价,通化金马股市,通化金马股票价格,通化金马股票交易,通化金马股票购买,通化金马股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}